Fibroblast-myocyte coupling in the heart: Potential relevance for therapeutic interventions

J Mol Cell Cardiol. 2016 Feb:91:238-46. doi: 10.1016/j.yjmcc.2016.01.010. Epub 2016 Jan 14.

Abstract

Cardiac myocyte-fibroblast electrotonic coupling is a well-established fact in vitro. Indirect evidence of its presence in vivo exists, but few functional studies have been published. This review describes the current knowledge of fibroblast-myocyte electrical signaling in the heart. Further research is needed to understand the frequency and extent of heterocellular interactions in vivo in order to gain a better understanding of their relevance in healthy and diseased myocardium. It is hoped that associated insight into myocyte-fibroblast coupling in the heart may lead to the discovery of novel therapeutic targets and the development of agents for improving outcomes of myocardial scarring and fibrosis.

Keywords: Cardiac electrophysiology; Gap junction; Scar.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cardiotonic Agents / therapeutic use
  • Cell Communication / drug effects
  • Cicatrix / genetics
  • Cicatrix / metabolism*
  • Cicatrix / pathology
  • Cicatrix / prevention & control
  • Connexins / genetics
  • Connexins / metabolism*
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism*
  • Fibroblasts / pathology
  • Fibrosis / genetics
  • Fibrosis / metabolism*
  • Fibrosis / pathology
  • Fibrosis / therapy
  • Gap Junctions / drug effects
  • Gene Expression Regulation
  • Heart Conduction System / drug effects
  • Humans
  • Membrane Potentials / drug effects
  • Myocardium / metabolism
  • Myocardium / pathology
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / metabolism*
  • Myocytes, Cardiac / pathology
  • Signal Transduction

Substances

  • Cardiotonic Agents
  • Connexins